Linagliptin
Overview
Linagliptin is a dipeptidyl peptidase 4 (DPP-4) inhibitor used as an oral hypoglycemic agent for the treatment of type 2 diabetes. It works by increasing the levels of incretin hormones, which inhibit glucagon release and increase insulin secretion.
API suppliers (28)
Suppliers of Linagliptin evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 22 of 28 suppliers.
14 of 28 hold a GMP certificate on record in the EU or UK registers
- Alembic Pharmaceuticals LimitedIndia2 active DMF GMP on record
- ALIVUS LIFE SCIENCES LTDIndia1 active DMF GMP on record
- BEIJING HUIKANG BOYUAN CHEMICAL TECH CO LTDChina1 active DMF
- MATRIX PHARMACORP PRIVATE LTDIndia1 active DMF
- Zhejiang Huahai Pharmaceutical Co., Ltd.China1 active DMF GMP on record
- TAPI NL BVNetherlands1 active DMF
- HONOUR LAB LTDIndia1 active DMF GMP on record
- APITORIA PHARMA PRIVATE LTDIndia1 active DMF GMP on record
- Sun Pharmaceutical Industries LimitedIndia1 active DMF GMP on record
- DR REDDYS LABORATORIES LTD1 active DMF GMP on record
- MOREPEN LABORATORIES LTDIndia1 active DMF GMP on record
- ZAKLADY FARMACEUTYCZNE POLPHARMA SA1 active DMF
- Macleods Pharmaceuticals Ltd.India1 active DMF GMP on record
- Wisdom Pharmaceutical Co., LtdChina1 active DMF
- Shanghai Wonder Pharmaceutical Co., LtdChina1 active DMF
- FUXIN LONG RUI PHARMACEUTICAL CO LTD1 active DMF
- CHIERON ACTIVE INGREDIENTS PRIVATE LTDIndia1 active DMF
- Biocon LimitedIndia1 active DMF
- OPTIMUS DRUGS PRIVATE LTDIndia1 active DMF
- LEE PHARMA LTDIndia1 active DMF GMP on record
- CENTAUR PHARMACEUTICALS PVT LTDIndia1 active DMF GMP on record
- HARMAN FINOCHEM LTDIndia1 active DMF GMP on record
- Granules India LimitedIndia1 active DMF GMP on record
- VIYASH SCIENTITIC LIMITED1 active DMF
- Shandong New Time Pharmaceutical Co Ltd1 active DMF GMP on record
Showing 25 of 28 suppliers — see the full list in the app.
Patent & exclusivity (US)
Per the FDA Orange Book (9 approved US products), the latest listed US patent on Linagliptin expires 8 Dec 2037 and exclusivity 20 Dec 2026. Generic API sourcing typically opens up once these lapse.
Therapeutic areas
Do you supply Linagliptin? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.